FluoroPharma Medical Inc. (FPMI) News Nov 14, 2014
Post# of 250675
Posted On: 11/17/2014 2:41:12 AM
FluoroPharma Medical Inc. (FPMI) News Nov 14, 2014, 8:10 p.m.
MarketWatch News on FPMI
No News currently available for FPMI
Advertisement
Other News on FPMI
Eagle Pharmaceuticals (EGRX) in Focus: Stock Moves 5.6% Higher - Tale of the Tape 8:21 a.m. July 1, 2014 - Zacks.com
10-Q: FLUOROPHARMA MEDICAL, INC. 3:44 p.m. May 15, 2014 - Edgar Online - (EDG = 10Q, 10K)
10-K: FLUOROPHARMA MEDICAL, INC. 5:07 a.m. March 25, 2014 - Edgar Online - (EDG = 10Q, 10K)
10-Q: FLUOROPHARMA MEDICAL, INC. 3:28 p.m. Aug. 19, 2013 - Edgar Online - (EDG = 10Q, 10K)
Market Trends Offer Opportunities for FPMI - Analyst Blog 12:01 p.m. May 20, 2013 - Zacks.com
10-Q: FLUOROPHARMA MEDICAL, INC. 4:03 p.m. May 15, 2013 - Edgar Online - (EDG = 10Q, 10K)
FPMI: CardioPET Excellent Image Quality from Phase II - Analyst Blog 4:16 p.m. Feb. 28, 2013 - Zacks.com
BFPET Phase II Trials Commence - Analyst Blog 2:35 p.m. Jan. 3, 2013 - Zacks.com
FPMI - Q2 2012 10-Q Filed - Analyst Blog 4:12 p.m. Aug. 20, 2012 - Zacks.com
BFPET Pre-Phase 2 Study Results Very Encouraging - Analyst Blog 11:37 a.m. July 27, 2012 - Zacks.com
Q1 10-Q, Development On-Track - Analyst Blog 8:16 a.m. May 17, 2012 - Zacks.com
FPMI: CardioPET Phase 2 Trials Initiated - Analyst Blog 7:57 a.m. March 22, 2012 - Zacks.com
FPMI: CardioPET Phase 2 Trials Initiated - Analyst Blog 7:57 a.m. March 22, 2012 - Zacks.com
Initiating Coverage of FluoroPharma Medical - Analyst Blog 11:57 a.m. Jan. 17, 2012 - Zacks.com
Press Releases on FPMI
Journal of Nuclear Cardiology Publication States Preliminary Findings of Phase II Clinical Study Suggest FluoroPharma's CardioPET Has a Promising Role for the Identification of Functionally Significant Coronary Artery Disease 8:55 a.m. Nov. 3, 2014 - Marketwired
FluoroPharma Announces That Data From Its Phase II Clinical Trial of 18-F FCPHA (CardioPET) Was Presented at the Annual Congress of the European Association of Nuclear Medicine (EANM), October 19, 2014, in Gothenburg, Sweden 7:32 a.m. Oct. 20, 2014 - Marketwired
FluoroPharma Medical Announces Acceptance of Abstract from Phase II Clinical Trial of CardioPET (18F FCPHA) for Oral Presentation at the Annual Congress of the European Association of Nuclear Medicine (EANM), October 18 - 22, 2014, in Gothenburg, Sweden 6:31 a.m. Oct. 6, 2014 - Marketwire
FluoroPharma Announces That Data From Its Phase II Clinical Trial of 18-F FCPHA (CardioPET) Was Presented at the 19th Annual Scientific Session of the American Society of Nuclear Cardiology (ASNC), September 20th in Boston, MA 10:26 a.m. Sept. 22, 2014 - Marketwire
FluoroPharma Medical Announces Acceptance of Abstract From Phase II Clinical Trial of CardioPET (18F FCPHA) for Oral Presentation at the 19th Annual Scientific Session of the American Society of Nuclear Cardiology (ASNC), September 18-21, 2014, in Boston 7:15 a.m. Sept. 2, 2014 - Marketwire
FluoroPharma Announces That Data From Its Phase II Clinical Trial of 18-F FCPHA (CardioPET) Was Presented at the Society of Nuclear Medicine and Molecular Imaging Annual Meeting, June 10th in St. Louis, MO 8:48 a.m. June 11, 2014 - Marketwire
FluoroPharma Medical Announces Presentation of Data From Phase II Clinical Trial of 18F FCPHA (CardioPET) at the Society of Nuclear Medicine and Molecular Imaging Annual Meeting, June 7-14, in St. Louis, MO 7:35 a.m. May 29, 2014 - Marketwire
FluoroPharma Medical Chairman & CEO to Present at 15th Annual B. Riley Conference on May 19th at 4:00 pm PDT 6:31 a.m. May 19, 2014 - Marketwire
The World Market for Cardiovascular Diagnostics 5:57 p.m. April 29, 2014 - PR Newswire - PRF
FluoroPharma Appoints Dr. H. William Strauss, Internationally Recognized Expert in the Field of Cardiovascular Nuclear Medicine, to Chair the Scientific Advisory Board 6:28 a.m. April 14, 2014 - Marketwire
FluoroPharma CEO Thijs Spoor to Be Interviewed Live Today on Clear Channel Business Talk Radio 7:16 a.m. April 2, 2014 - Marketwire
FluoroPharma Announces Appointment of Andrew H. Sassine to the Board of Directors 6:34 a.m. March 11, 2014 - Marketwire
Data Presented From FluoroPharma's Phase II Clinical Trial of CardioPET (18F FCPHA) for Assessment of Acute and Chronic Forms of Coronary Artery Disease (CAD) 12:59 p.m. Feb. 6, 2014 - Marketwire
FluoroPharma CEO, Thijs Spoor, to Present Business and Portfolio Updates at the Noble Financial Capital Markets' Tenth Annual Equity Conference January 20, 2014 1:03 p.m. Jan. 15, 2014 - Marketwire
FluoroPharma CEO Thijs Spoor to Provide Business and Portfolio Update at Biotech Showcase 2014 in San Francisco, January 13th-15th 3:06 p.m. Jan. 8, 2014 - Marketwire
FluoroPharma Medical Announces Acceptance of Abstract for Oral Presentation at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Winter Meeting 7:31 a.m. Dec. 19, 2013 - Marketwire
FluoroPharma Medical Inc. to Present at the LD Micro Sixth Annual Conference on December 5, 2013 8:40 a.m. Nov. 27, 2013 - Marketwire
FluoroPharma Medical Inc. Is Elected to the Medical Imaging & Technology Alliance (MITA) 9:54 a.m. Nov. 25, 2013 - Marketwire
FluoroPharma Medical, Inc. Names GE Healthcare Veteran, Edward L. Lyons, Jr. to Newly Created Position of Vice President, Marketing 6:46 a.m. Oct. 28, 2013 - Marketwire
FluoroPharma Medical, Inc. Announces Closing of Equity Financing 6:14 a.m. Sept. 19, 2013 - Marketwire
Loading more headlines...
MarketWatch News on FPMI
No News currently available for FPMI
Advertisement
Other News on FPMI
Eagle Pharmaceuticals (EGRX) in Focus: Stock Moves 5.6% Higher - Tale of the Tape 8:21 a.m. July 1, 2014 - Zacks.com
10-Q: FLUOROPHARMA MEDICAL, INC. 3:44 p.m. May 15, 2014 - Edgar Online - (EDG = 10Q, 10K)
10-K: FLUOROPHARMA MEDICAL, INC. 5:07 a.m. March 25, 2014 - Edgar Online - (EDG = 10Q, 10K)
10-Q: FLUOROPHARMA MEDICAL, INC. 3:28 p.m. Aug. 19, 2013 - Edgar Online - (EDG = 10Q, 10K)
Market Trends Offer Opportunities for FPMI - Analyst Blog 12:01 p.m. May 20, 2013 - Zacks.com
10-Q: FLUOROPHARMA MEDICAL, INC. 4:03 p.m. May 15, 2013 - Edgar Online - (EDG = 10Q, 10K)
FPMI: CardioPET Excellent Image Quality from Phase II - Analyst Blog 4:16 p.m. Feb. 28, 2013 - Zacks.com
BFPET Phase II Trials Commence - Analyst Blog 2:35 p.m. Jan. 3, 2013 - Zacks.com
FPMI - Q2 2012 10-Q Filed - Analyst Blog 4:12 p.m. Aug. 20, 2012 - Zacks.com
BFPET Pre-Phase 2 Study Results Very Encouraging - Analyst Blog 11:37 a.m. July 27, 2012 - Zacks.com
Q1 10-Q, Development On-Track - Analyst Blog 8:16 a.m. May 17, 2012 - Zacks.com
FPMI: CardioPET Phase 2 Trials Initiated - Analyst Blog 7:57 a.m. March 22, 2012 - Zacks.com
FPMI: CardioPET Phase 2 Trials Initiated - Analyst Blog 7:57 a.m. March 22, 2012 - Zacks.com
Initiating Coverage of FluoroPharma Medical - Analyst Blog 11:57 a.m. Jan. 17, 2012 - Zacks.com
Press Releases on FPMI
Journal of Nuclear Cardiology Publication States Preliminary Findings of Phase II Clinical Study Suggest FluoroPharma's CardioPET Has a Promising Role for the Identification of Functionally Significant Coronary Artery Disease 8:55 a.m. Nov. 3, 2014 - Marketwired
FluoroPharma Announces That Data From Its Phase II Clinical Trial of 18-F FCPHA (CardioPET) Was Presented at the Annual Congress of the European Association of Nuclear Medicine (EANM), October 19, 2014, in Gothenburg, Sweden 7:32 a.m. Oct. 20, 2014 - Marketwired
FluoroPharma Medical Announces Acceptance of Abstract from Phase II Clinical Trial of CardioPET (18F FCPHA) for Oral Presentation at the Annual Congress of the European Association of Nuclear Medicine (EANM), October 18 - 22, 2014, in Gothenburg, Sweden 6:31 a.m. Oct. 6, 2014 - Marketwire
FluoroPharma Announces That Data From Its Phase II Clinical Trial of 18-F FCPHA (CardioPET) Was Presented at the 19th Annual Scientific Session of the American Society of Nuclear Cardiology (ASNC), September 20th in Boston, MA 10:26 a.m. Sept. 22, 2014 - Marketwire
FluoroPharma Medical Announces Acceptance of Abstract From Phase II Clinical Trial of CardioPET (18F FCPHA) for Oral Presentation at the 19th Annual Scientific Session of the American Society of Nuclear Cardiology (ASNC), September 18-21, 2014, in Boston 7:15 a.m. Sept. 2, 2014 - Marketwire
FluoroPharma Announces That Data From Its Phase II Clinical Trial of 18-F FCPHA (CardioPET) Was Presented at the Society of Nuclear Medicine and Molecular Imaging Annual Meeting, June 10th in St. Louis, MO 8:48 a.m. June 11, 2014 - Marketwire
FluoroPharma Medical Announces Presentation of Data From Phase II Clinical Trial of 18F FCPHA (CardioPET) at the Society of Nuclear Medicine and Molecular Imaging Annual Meeting, June 7-14, in St. Louis, MO 7:35 a.m. May 29, 2014 - Marketwire
FluoroPharma Medical Chairman & CEO to Present at 15th Annual B. Riley Conference on May 19th at 4:00 pm PDT 6:31 a.m. May 19, 2014 - Marketwire
The World Market for Cardiovascular Diagnostics 5:57 p.m. April 29, 2014 - PR Newswire - PRF
FluoroPharma Appoints Dr. H. William Strauss, Internationally Recognized Expert in the Field of Cardiovascular Nuclear Medicine, to Chair the Scientific Advisory Board 6:28 a.m. April 14, 2014 - Marketwire
FluoroPharma CEO Thijs Spoor to Be Interviewed Live Today on Clear Channel Business Talk Radio 7:16 a.m. April 2, 2014 - Marketwire
FluoroPharma Announces Appointment of Andrew H. Sassine to the Board of Directors 6:34 a.m. March 11, 2014 - Marketwire
Data Presented From FluoroPharma's Phase II Clinical Trial of CardioPET (18F FCPHA) for Assessment of Acute and Chronic Forms of Coronary Artery Disease (CAD) 12:59 p.m. Feb. 6, 2014 - Marketwire
FluoroPharma CEO, Thijs Spoor, to Present Business and Portfolio Updates at the Noble Financial Capital Markets' Tenth Annual Equity Conference January 20, 2014 1:03 p.m. Jan. 15, 2014 - Marketwire
FluoroPharma CEO Thijs Spoor to Provide Business and Portfolio Update at Biotech Showcase 2014 in San Francisco, January 13th-15th 3:06 p.m. Jan. 8, 2014 - Marketwire
FluoroPharma Medical Announces Acceptance of Abstract for Oral Presentation at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Winter Meeting 7:31 a.m. Dec. 19, 2013 - Marketwire
FluoroPharma Medical Inc. to Present at the LD Micro Sixth Annual Conference on December 5, 2013 8:40 a.m. Nov. 27, 2013 - Marketwire
FluoroPharma Medical Inc. Is Elected to the Medical Imaging & Technology Alliance (MITA) 9:54 a.m. Nov. 25, 2013 - Marketwire
FluoroPharma Medical, Inc. Names GE Healthcare Veteran, Edward L. Lyons, Jr. to Newly Created Position of Vice President, Marketing 6:46 a.m. Oct. 28, 2013 - Marketwire
FluoroPharma Medical, Inc. Announces Closing of Equity Financing 6:14 a.m. Sept. 19, 2013 - Marketwire
Loading more headlines...
(0)
(0)